Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1816 AL 1830

Comment on "The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials"

Nogueira LO, Boone DL.

Parkinsonism Relat Disord. 2025 Feb;131:107223. doi: 10.1016/j.parkreldis.2024.107223. Epub 2024 Dec 4.

Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin

Spencer PS, Berntsson SG, Buguet A, Butterfield P, Calne DB, Calne SM, Giménez-Roldán S, Hugon J, Kahlon S, Kisby GE, Lagrange E, Landtblom AE, Ludolph AC, Nunn PB, Palmer VS, Reis J, Román GC, Sipilä JOT, Spencer SS, Angues RV, Vernoux JP, Yabushita M.

J Neurol Sci. 2025 Jan 15;468:123340. doi: 10.1016/j.jns.2024.123340. Epub 2024 Dec 9.

Effects of non-invasive brain stimulation over the supplementary motor area on motor function in Parkinson's disease: A systematic review and meta-analysis

Chen Y, Jiang H, Wei Y, Ye S, Jiang J, Mak MKY, Pang MYC, Gao Q, Huang M.

Brain Stimul. 2025 Jan-Feb;18(1):1-14. doi: 10.1016/j.brs.2024.12.005. Epub 2024 Dec 11.

From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies

Wiseman JA, Reddy K, Dieriks BV.

Ageing Res Rev. 2025 Feb;104:102640. doi: 10.1016/j.arr.2024.102640. Epub 2024 Dec 10.

Glial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities

Liu Y, Wu L, Peng W, Mao X.

Ageing Res Rev. 2025 Feb;104:102638. doi: 10.1016/j.arr.2024.102638. Epub 2024 Dec 12.

Modifiable lifestyle factors influencing neurological and psychiatric disorders mediated by structural brain reserve: An observational and Mendelian randomization study

Dong Y, Zhang P, Zhong J, Wang J, Xu Y, Huang H, Liu X, Sun W.

J Affect Disord. 2025 Mar 1;372:440-450. doi: 10.1016/j.jad.2024.12.038. Epub 2024 Dec 11.

The comparative analysis between sporadic and genetic Creutzfeldt-Jakob disease in China

Li X, Chen Q, Zou X, Shen M, Han Z.

Acta Neurol Belg. 2025 Apr;125(2):369-376. doi: 10.1007/s13760-024-02698-4. Epub 2024 Dec 14.

Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies

Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A.

Ageing Res Rev. 2025 Feb;104:102639. doi: 10.1016/j.arr.2024.102639. Epub 2024 Dec 16.

Co-occurrence of Parkinson's disease and Retinitis Pigmentosa: A genetic and in silico analysis

Dwivedi A, Kumar A, Faruq M, Singh VK, Dwivedi N, Singh K, Hussain I, Parida S, Kumar Jha G, Kumar N, Joshi D.

Neuroscience. 2025 Jan 26;565:519-526. doi: 10.1016/j.neuroscience.2024.12.019. Epub 2024 Dec 12.

Carnitine supplementation in progressive supranuclear palsy

Dixit D, Zhao Y, Bardhi O, Daneshmand A, Phillips J, Bala T, Rosenthal M, Mohr A, Kandiah P, Kamel AY.

Nutr Clin Pract. 2025 Jun;40(3):742-747. doi: 10.1002/ncp.11262. Epub 2024 Dec 15.

Harmonic activity of glutamate dehydrogenase and neuroplasticity: The impact on aging, cognitive dysfunction, and neurodegeneration

Salarvandian S, Digaleh H, Khodagholi F, Javadpour P, Asadi S, Zaman AAO, Dargahi L.

Behav Brain Res. 2025 Mar 5;480:115399. doi: 10.1016/j.bbr.2024.115399. Epub 2024 Dec 13.

ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine

Quan Z, Wang S, Xie H, Zhang J, Duan R, Li M, Zhang J.

Small. 2025 Feb;21(5):e2410031. doi: 10.1002/smll.202410031. Epub 2024 Dec 15.

Influence of the Gut Microbiota, Metabolism and Environment on Neuropsychiatric Disorders

Wang M, Ma Y, Zeng B, Yang W, Huang C, Tang B.

Curr Rev Clin Exp Pharmacol. 2025;20(4):334-348. doi: 10.2174/0127724328335219241202142003.

Immune mechanisms and shared immune targets in neurodegenerative diseases

Weiner HL.

Nat Rev Neurol. 2025 Feb;21(2):67-85. doi: 10.1038/s41582-024-01046-7. Epub 2024 Dec 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias